Submit Deal

1AB

Summary

1AB is a strategic external communications partner to the C-suite and communications heads of startup, development-stage and commercial-stage life sciences companies.

Market Context

Deals Overview

Edit Data

Total Deals25

Valued Deals23

Total Value£ 8.35 B

Avg. Deal Size£ 363 M

01 Jul 2025|United States|Biotechnology

Target: SYNTIS BIO INC

Bidder: CERBERUS CAPITAL MANAGEMENT LP

4 Service Providers

2 Target | 2 Bidder

4 Dealmakers

2 Target | 2 Bidder

£ 24 M

Value

24 Jun 2025|United States|Biotechnology

Target: NEURON23

Bidder: WESTLAKE VILLAGE BIOPARTNERS

2 Service Providers

2 Target

2 Dealmakers

2 Target

£ 71 M

Value

18 Jun 2025|United States|Biotechnology

Target: ACTIO BIOSCIENCES INC

Bidder: REGENERON VENTURES

3 Service Providers

2 Target | 1 Bidder

3 Dealmakers

2 Target | 1 Bidder

£ 49 M

Value

17 Jun 2025|United States|Biotechnology

Target: VERVE THERAPEUTICS

Bidder: ELI LILLY AND COMPANY

7 Service Providers

5 Target | 2 Bidder

31 Dealmakers

20 Target | 11 Bidder

£ 1.11 B

Value

03 Dec 2024|United States|Biotechnology

Target: MAZE THERAPEUTICS

Bidder: JANUS HENDERSON INVESTORS

6 Service Providers

3 Target | 3 Bidder

5 Dealmakers

3 Target | 2 Bidder

£ 90 M

Value

08 Oct 2024|United States|Biotechnology

Target: CITY THERAPEUTICS

Bidder: REGENERON

4 Service Providers

3 Target | 1 Bidder

5 Dealmakers

4 Target | 1 Bidder

£ 103 M

Value

07 Aug 2024|United States|Biotechnology

Target: IDRX

Bidder: ANDREESSEN HOROWITZ LLC (A16Z)

12 Service Providers

2 Target | 10 Bidder

11 Dealmakers

2 Target | 9 Bidder

£ 94 M

Value

18 Jun 2024|United States|Biotechnology

Target: MAREA THERAPEUTICS

Bidder: PERCEPTIVE XONTOGENY VENTURE FUND

5 Service Providers

2 Target | 3 Bidder

5 Dealmakers

3 Target | 2 Bidder

£ 149 M

Value

18 Apr 2024|United States|Health Care Services

Target: METSERA

Bidder: MUBADALA CAPITAL

5 Service Providers

2 Target | 3 Bidder

17 Dealmakers

2 Target | 15 Bidder

£ 232 M

Value

21 Mar 2024|United States|Pharmaceuticals

Target: MIRADOR THERAPEUTICS

Bidder: ORBIMED ADVISORS LLC

4 Service Providers

3 Target | 1 Bidder

7 Dealmakers

6 Target | 1 Bidder

£ 314 M

Value

20 Jun 2023|United States|Pharmaceuticals

Target: DICE THERAPEUTICS

Bidder: ELI LILLY AND COMPANY

7 Service Providers

5 Target | 2 Bidder

37 Dealmakers

34 Target | 3 Bidder

£ 1.87 B

Value

26 Apr 2023|United States|Biotechnology

Target: ORBITAL THERAPEUTICS

Bidder: NEWPATH PARTNERS

5 Service Providers

3 Target | 2 Bidder

4 Dealmakers

3 Target | 1 Bidder

£ 216 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy